- Home
- AVAH vs CVAC Comparison
AVAH vs CVAC Comparison
Compare AVAH & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAH
- CVAC
- Stock Information
- Founded
- AVAH 1984
- CVAC 2000
- Country
- AVAH United States
- CVAC Germany
- Employees
- AVAH N/A
- CVAC N/A
- Industry
- AVAH Hospital/Nursing Management
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- AVAH Health Care
- CVAC Health Care
- Exchange
- AVAH Nasdaq
- CVAC Nasdaq
- Market Cap
- AVAH 783.0M
- CVAC 720.0M
- IPO Year
- AVAH 2021
- CVAC 2020
- Fundamental
- Price
- AVAH $5.38
- CVAC $3.23
- Analyst Decision
- AVAH Hold
- CVAC Hold
- Analyst Count
- AVAH 4
- CVAC 3
- Target Price
- AVAH $4.27
- CVAC $10.00
- AVG Volume (30 Days)
- AVAH 298.3K
- CVAC 497.5K
- Earning Date
- AVAH 11-07-2024
- CVAC 08-15-2024
- Dividend Yield
- AVAH N/A
- CVAC N/A
- EPS Growth
- AVAH N/A
- CVAC N/A
- EPS
- AVAH N/A
- CVAC N/A
- Revenue
- AVAH $1,952,462,000.00
- CVAC $70,565,734.00
- Revenue This Year
- AVAH $7.16
- CVAC $183.73
- Revenue Next Year
- AVAH $5.12
- CVAC N/A
- P/E Ratio
- AVAH N/A
- CVAC N/A
- Revenue Growth
- AVAH 6.55
- CVAC 75.11
- 52 Week Low
- AVAH $0.85
- CVAC $2.22
- 52 Week High
- AVAH $5.87
- CVAC $8.25
- Technical
- Relative Strength Index (RSI)
- AVAH 58.06
- CVAC 50.44
- Support Level
- AVAH $4.80
- CVAC $2.91
- Resistance Level
- AVAH $5.45
- CVAC $3.44
- Average True Range (ATR)
- AVAH 0.33
- CVAC 0.19
- MACD
- AVAH -0.08
- CVAC 0.04
- Stochastic Oscillator
- AVAH 63.81
- CVAC 67.62
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is primarily derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.